Foundation for innovation
in Cardiometabolism and Nutrition

Flecainide to prevent atrial arrhythmia after patent foramen ovale closure, Rationale and design of the randomized AFLOAT study

European Heart Journal – Cardiovascular Pharmacotherapy

Flecainide to prevent atrial arrhythmia after patent foramen ovale closure, Rationale and design of the randomized AFLOAT study

Nos soutiens institutionnels

Notre réseau